Explore 3 Stock Ideas & Industry Insights Download Free Report

News

Navitas Semiconductor (NASDAQ: NVTS) — Electrification Theme Gains Momentum

Navitas (NASDAQ:NVTS) advanced 19.61% to $9.88, with 41.80 million shares traded (3.22x relative volume).Market cap: $2.28 billion (EODHD/Others data as of February 25, 2026).

Anjali Anand | 26 February 2026

Wall Street Awaits NVIDIA’s Crucial Q4 Earnings Report

As U.S. equity futures edge higher, institutional investors are turning their attention to one event that could define near-term stock market direction: the fourth-quarter earnings release from NVIDIA.

Nitish Kishor | 25 February 2026

First Solar Shares Fall 19% as Guidance Resets Expectations

First Solar, Inc. (NASDAQ: FSLR) saw its stock decline approximately 19% following the release of fourth-quarter 2025 results and 2026 guidance.

Nitish Kishor | 25 February 2026

Markets Edge Higher Amid AI Optimism, Tariff Uncertainty, and Steady Fed Signals

Market Movers:On Tuesday, the top gainers were Rich Sparkle Holdings Limited (+52.93%), followed by Brand Engagement Network Inc. (+40.23%). On the contrary, Claritev Corporation (-41.58%), and DMC Global Inc. (-32.95%) declined the most the same day.

Team Kalkine | 25 February 2026

Keysight Technologies (NYSE: KEYS) Surges 23% to $301.48: Strong Financials & Bullish Technical Breakout

Keysight Technologies (NYSE:KEYS) jumped23.05% to $301.48 (February 24, 2026)following a strong investor reaction.

Anjali Anand | 25 February 2026

Kelly Services (NASDAQ:KELYB) Gains 27% to $16.52: Earnings Strength & Technical Momentum

Kelly Services Inc Class B (NASDAQ:KELYB) rose26.59% to $16.52 (February 24, 2026)amid optimism around staffing sector resilience. Improving labor demand, margin expansion, or an earnings surprise likely drove the surge.

Anjali Anand | 25 February 2026

Iovance Biotherapeutics (NASDAQ:IOVA) Rallies 31% to $3.78: Financial Growth Potential & Technical Setup

Iovance Biotherapeutics Inc (NASDAQ:IOVA) climbed30.80% to $3.78 (February 24, 2026)as biotech investors rotated into oncology-focused growth names.

Anjali Anand | 25 February 2026

Clarivate (NYSE:CLVT) Stock Soars 40% to $2.35: Financials, Technical Breakout & 2026 Outlook

Clarivate Plc (NYSE:CLVT) surged39.88% to $2.35 (February 24, 2026), emerging as one of the top percentage gainers among US-listedmid-capstocks. The sharp rally has sparked investor interest in Clarivate’s financial health, turnaround strategy, and technical setup.

Anjali Anand | 25 February 2026

Vir Biotechnology (NASDAQ:VIR) Jumps over 27% to $9.49: Financial Position & Breakout Analysis

Vir Biotechnology Inc (NASDAQ:VIR) surged27.73% to $9.49 (February 24, 2026), driven by renewed biotech momentum and pipeline expectations.

Anjali Anand | 25 February 2026

Circle (NASDAQ: CRCL) Stock Explodes 22% as Stablecoin Giant Crushes Earning, But the Fed Could Kill It Tomorrow

USDC issuer triples Wall Street estimates with $770M revenue surge, yet entire profit model hangs on interest rates Powell may slash within months.

Nitish Kishor | 25 February 2026
Support

Hi! How can we help you today?

Loading…